11/19/2024
11:15 PM | Sangamo Therapeutics (Filer)
| Form EFFECT | |
11/12/2024
3:53 PM | Sangamo Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
12:54 PM | Sangamo Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/28/2024
3:11 PM | Davis Gregory D (Reporting)
Sangamo Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/27/2024
3:36 PM | Macrae Sandy (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
3:37 PM | Dubois-Stringfellow Nathalie (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
3:37 PM | Duraibabu Prathyusha (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/27/2024
3:38 PM | Pooler Amy (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
3:38 PM | Sangamo Therapeutics (Issuer)
Willoughby Scott B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
5:40 PM | BIOGEN INC. (Filed by)
Sangamo Therapeutics (Subject)
| Form SC 13G/A | |
08/15/2024
3:34 PM | Sangamo Therapeutics (Issuer)
Willoughby Scott B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2024
3:05 PM | Sangamo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
3:32 PM | BlackRock Inc. (Filed by)
Sangamo Therapeutics (Subject)
| Form SC 13G/A | |
06/13/2024
3:42 PM | Duraibabu Prathyusha (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
4:10 PM | Sangamo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2024
4:18 PM | Dubois-Stringfellow Nathalie (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
3:57 PM | Duraibabu Prathyusha (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:00 PM | Pooler Amy (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
3:14 PM | Sangamo Therapeutics (Filer)
| Form ARS | |
03/25/2024
4:04 PM | Sangamo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
6:55 AM | Sangamo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
6:47 AM | Sangamo Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/12/2024
6:11 PM | BIOGEN INC. (Filed by)
Sangamo Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
11:17 AM | Sangamo Therapeutics (Subject)
WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
02/06/2024
3:35 PM | Sangamo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2024
3:40 PM | Dubois-Stringfellow Nathalie (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
3:41 PM | Duraibabu Prathyusha (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
3:42 PM | Sangamo Therapeutics (Issuer)
Willoughby Scott B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
3:42 PM | Pooler Amy (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
3:39 PM | Macrae Sandy (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
11:18 AM | Sangamo Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/19/2024
4:09 PM | Sangamo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2023
6:55 AM | Sangamo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/28/2023
3:15 PM | Pooler Amy (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/28/2023
3:16 PM | Dubois-Stringfellow Nathalie (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/28/2023
3:17 PM | Duraibabu Prathyusha (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/28/2023
3:18 PM | Fontenot Jason D. (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/28/2023
3:19 PM | Macrae Sandy (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/28/2023
3:19 PM | McClung David Mark (Reporting)
Sangamo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/28/2023
3:20 PM | Sangamo Therapeutics (Issuer)
Willoughby Scott B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
